Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Listing"

84 News Found

Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal
News | May 06, 2026

Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal

The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty


Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate
News | May 02, 2026

Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate

Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right


Sai Life Sciences allots 2.44 lakh equity shares under employee stock option schemes
News | April 24, 2026

Sai Life Sciences allots 2.44 lakh equity shares under employee stock option schemes

Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms


Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations
People | April 24, 2026

Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations

Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business


Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court
News | April 20, 2026

Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court

The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage


Anlon Healthcare gets Brickwork rating withdrawal after facility closure
News | April 16, 2026

Anlon Healthcare gets Brickwork rating withdrawal after facility closure

This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities


Teva launches Home Ground platform to tackle isolation in schizophrenia care
Digitisation | April 16, 2026

Teva launches Home Ground platform to tackle isolation in schizophrenia care

The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping


Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
News | April 11, 2026

Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE

Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter


Zydus improves ESG rating to 68, up from 66 last year
News | April 11, 2026

Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker


Sun Pharma appoints former PwC India COO Satyavati Berera as independent director
Appointment | April 05, 2026

Sun Pharma appoints former PwC India COO Satyavati Berera as independent director

Board approves five-year appointment, subject to shareholder nod through postal ballot